Prestigious Prize Recognizes Pioneering Body's Defenses Research
The Nobel Prize in medical science has been granted for revolutionary discoveries that clarify how the body's defense network attacks dangerous pathogens while protecting the body's own cells.
A trio of esteemed researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this honor.
Their work identified specialized "security guards" within the immune system that eliminate malfunctioning immune cells that could attacking the body.
The findings are now paving the way for new treatments for autoimmune diseases and malignancies.
The winners will divide a prize fund valued at 11m Swedish kronor.
Crucial Findings
"Their work has been essential for comprehending how the immune system functions and the reason we do not all develop serious autoimmune diseases," commented the head of the award panel.
The team's studies address a core mystery: How does the defense system defend us from countless invaders while leaving our healthy cells intact?
The immune system employs immune cells that scan for indicators of infection, even viruses and bacteria it has never encountered.
Such cells employ detectors—known as receptors—that are generated by chance in a vast number of combinations.
That gives the immune system the ability to fight a wide array of threats, but the randomness of the mechanism inevitably creates white blood cells that can target the body.
Security Guards of the Immune System
Researchers earlier understood that some of these problematic white blood cells were eliminated in the immune organ—where white blood cells mature.
The latest Nobel Prize honors the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize any immune cells that assault the body's own tissues.
We know that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.
A Nobel panel stated, "These findings have established a novel area of research and accelerated the development of innovative treatments, for instance for tumors and autoimmune diseases."
Regarding cancer, T-regs prevent the system from fighting the tumor, so research are focused on lowering their quantity.
For autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable method could also be effective in minimizing the risks of organ transplant rejection.
Innovative Experiments
Prof Shimon Sakaguchi, from Osaka University, performed experiments on mice that had their immune gland removed, causing self-attack conditions.
He showed that injecting immune cells from healthy mice could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the body.
Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a gene critical for how T-regs operate.
"Their groundbreaking work has uncovered how the immune system is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a leading physiology expert.
"This research is a remarkable example of how fundamental biological study can have far-reaching consequences for public health."
